Former international cricketer Emma Beamish on living with the anxiety of never knowing when it might strike again, and her ...

Epilepsy SA, based in Springs, is an organisation that has cared for individuals living with epilepsy for many years. To raise awareness about the disorder, the organisation shared more about epilepsy ...

What is Driving the Growth of the Neurological Disorder Diagnostics Market?The global neurological disorder diagnostics market is experiencing significant growth, driven by the increasing prevalence ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

Using a single-cell sequencing technique, Brazilian researchers have created the first cell atlas of focal cortical dysplasia ...

The 2024 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Praxis, or following a bona fide period of non-employment, as an ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal exc ...

The eruption of digital technologies and ICT has meant that, in recent decades, there has been an enormous presence of screens in people's lives and, above ...